Furthermore, gliomas are not considered highly immunogenic due to the low mutational loads, besides they are featured by severe immunosuppression mediated by immune-inhibitory factors, such as programmed cell-death 1 ligand 1 (PDCD1LG1) and secreted transforming growth factor β (Nduom et al., 2015). The gene discussed is CD274; the disease is glioma.